Showing results (401-410 of 1,033) with videos related to
Sort By:
Pageof 104
The Prostate|August 23, 2018
Heritable methylation marks associated with breast and prostate cancer riskPierre-Antoine Dugué, James G Dowty, Jihoon E Joo, et al.Ophthalmic Epidemiology|March 18, 2015
Age-related macular degeneration in ethnically diverse Australia: Melbourne Collaborative Cohort StudyLiubov D Robman, Fakir M A Islam, Elaine W T Chong, et al.International Journal of Cancer|February 17, 2019
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosisHarindra Jayasekara, Robert J MacInnis, James A Chamberlain, et al.Transfusion|October 12, 2011
A comparison of self-reported and record-linked blood donation history in an Australian cohortNadine A Bertalli, Katrina J Allen, Christine E McLaren, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutationsRoger L Milne, Julia A Knight, Esther M John, et al.Journal of Gastroenterology and Hepatology|October 15, 2014
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year studySophie G Zaloumis, Katrina J Allen, Nadine A Bertalli, et al.British Journal of Cancer|November 20, 2025
Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomyYiyue Zhu, Elaheh Zarean, Danmeng L Li, et al.Breast Cancer Research : BCR|December 25, 2010
A PALB2 mutation associated with high risk of breast cancerMelissa C Southey, Zhi L Teo, James G Dowty, et al.BMC Cancer|May 19, 2023
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survivalElena A Takano, Melissa M Younes, Katie Meehan, et al.Pageof 104